Quantcast

J&J Developing Several Next-gen Covid-19 Vaccines, CEO Says

covid-19 vaccine
Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration

Johnson & Johnson is developing several next generation COVID-19 vaccines against the emerging variants of the coronavirus, Chief Executive Officer Alex Gorsky said on Thursday.

The drugmaker, which won the U.S. emergency use authorization of a one-shot vaccine last month, had previously said it was developing a second-generation vaccine that would target the variant first identified in South Africa. J&J is also working on a two-dose version of its vaccine.

“We could be in a situation where you could either need a booster to maintain the durability (of protection against the virus) or you might need to have a next derivative of the current vaccine to address these variants as they develop”, Gorsky said at a webinar by the Economic Club of New York.

Sign up for Long Island Press’ email newsletters hereSign up for home delivery of Long Island Press here. Sign up for discounts by becoming a Long Island Press community partner here.